美国FDA 指导原则 符合21 CFR第4部分工业指南的某些眼科产品政策 英文原版.pdfVIP

Certain Ophthalmic Products: Policy Regarding Compliance With 21 CFR Part 4 Guidance for Industry This guidance is for immediate implementation. FDA is issuing this guidance for immediate implementation in accordance with 21 CFR 10.115(g)(2). Submit one set of either electronic or written comments on this guidance at any time. Submit electronic comments to . Submit written comments to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. You should identify a